ArticleDiabetes, obesity & metabolism2026

Cardiovascular Outcomes With SGLT-2 Inhibitors in Patients With Type 2 Diabetes and Obstructive Sleep Apnoea: A Real-World Analysis.

Reuben L Odai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.